Robert Thomas Freeman Sells 14,692 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Robert Thomas Freeman sold 14,692 shares of the stock in a transaction on Wednesday, March 12th. The shares were sold at an average price of $15.43, for a total value of $226,697.56. Following the completion of the transaction, the chief financial officer now directly owns 1,402,862 shares of the company’s stock, valued at approximately $21,646,160.66. This represents a 1.04 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Robert Thomas Freeman also recently made the following trade(s):

• On Thursday, March 6th, Robert Thomas Freeman sold 218,295 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.53, for a total value of $3,390,121.35.
• On Tuesday, March 4th, Robert Thomas Freeman sold 250,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.58, for a total value of $3,895,000.00.

Alignment Healthcare Stock Up 1.9 %

Shares of NASDAQ:ALHC opened at $15.79 on Friday. The business has a 50-day moving average price of $14.38 and a 200 day moving average price of $12.41. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82. The company has a market capitalization of $3.03 billion, a price-to-earnings ratio of -20.51 and a beta of 1.49. Alignment Healthcare, Inc. has a 12-month low of $4.46 and a 12-month high of $16.25.

Institutional Trading of Alignment Healthcare

A number of hedge funds and other institutional investors have recently modified their holdings of ALHC. R Squared Ltd acquired a new stake in shares of Alignment Healthcare during the 4th quarter worth about $55,000. RiverPark Advisors LLC acquired a new position in Alignment Healthcare in the 4th quarter valued at about $106,000. Tower Research Capital LLC TRC grew its position in Alignment Healthcare by 146.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company’s stock valued at $119,000 after acquiring an additional 6,286 shares in the last quarter. Ballentine Partners LLC acquired a new position in Alignment Healthcare in the 4th quarter valued at about $121,000. Finally, Aigen Investment Management LP acquired a new position in Alignment Healthcare in the 4th quarter valued at about $129,000. 86.19% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts recently commented on the company. JPMorgan Chase & Co. increased their price objective on Alignment Healthcare from $14.00 to $17.00 and gave the company a “neutral” rating in a research note on Thursday, March 6th. Barclays increased their price objective on Alignment Healthcare from $8.00 to $9.00 and gave the company an “underweight” rating in a research note on Friday, February 28th. William Blair reissued an “outperform” rating on shares of Alignment Healthcare in a research note on Friday, February 28th. Stifel Nicolaus raised their target price on Alignment Healthcare from $16.00 to $18.00 and gave the stock a “buy” rating in a research note on Friday, February 28th. Finally, Bank of America raised their target price on Alignment Healthcare from $15.50 to $18.50 and gave the stock a “buy” rating in a research note on Tuesday, March 4th. One research analyst has rated the stock with a sell rating, three have given a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $14.83.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.